Cipla is preparing to enter the weight-loss drug making sector, heating the competition with US-based Eli Lilly & Co and Danish firm Novo Nordisk.

When a U.S. president threatens your industry with a 200% tariff, that’s not typically good news. But since Tuesday, when Donald Trump said in a cabinet meeting that imported pharmaceuticals would ...

Pharmaceutical giant Cipla plans to enter India's weight management sector, while also bolstering its central nervous system ...

In patients with metabolic-associated steatotic liver disease or metabolic-associated steatohepatitis, resmetirom and ...